MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Operating Expenses came in at $48.9 million in Q4 2025, down 7.54% YoY from $52.9 million in Q4 2024, and up 5.23% on a QoQ basis from $46.5 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Operating Expenses data on file, last reported at $48.9 million in Q4 2025.

  • Quarterly Operating Expenses fell 7.54% year-over-year to $48.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $187.4 million (down 5.13% YoY) and the FY2025 annual result came in at $187.4 million, down 5.13% from the prior year.
  • Operating Expenses rose to $48.9 million in Q4 2025, from $46.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $52.9 million in Q4 2024 to a low of $25.6 million in Q2 2021.
  • A 5-year average of $38.9 million and a median of $36.8 million in 2022 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2021 — Operating Expenses soared 118.16% — and 2025, when it slipped 8.81%.
  • Tracing MGTX's Operating Expenses over 5 years: stood at $28.7 million in 2021, then rose by 24.48% to $35.8 million in 2022, then rose by 28.03% to $45.8 million in 2023, then increased by 15.47% to $52.9 million in 2024, then fell by 7.54% to $48.9 million in 2025.
  • The last three Operating Expenses figures came in at $48.9 million (Q4 2025), $46.5 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 77.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.01 Mn
Dec 31, 2025 48.89 Mn
Sep 30, 2025 46.46 Mn
Jun 30, 2025 48.48 Mn
Mar 31, 2025 43.52 Mn
Dec 31, 2024 52.88 Mn
Sep 30, 2024 50.95 Mn
Jun 30, 2024 46.19 Mn
Mar 31, 2024 47.47 Mn
Dec 31, 2023 45.79 Mn
Sep 30, 2023 37.87 Mn
Jun 30, 2023 32.33 Mn
Mar 31, 2023 35.09 Mn
Dec 31, 2022 35.77 Mn
Sep 30, 2022 27.62 Mn
Jun 30, 2022 34.52 Mn
Mar 31, 2022 34.37 Mn
Dec 31, 2021 28.73 Mn
Sep 30, 2021 29.50 Mn
Jun 30, 2021 25.60 Mn